The Access Board has lead the effort to develop guidance on making prescription drug labels accessible to people with vision impairments.
The Food and Drug Administration Safety and Innovation Act of 2012 includes measures to promote drug safety and to improve FDA procedures for reviewing new medicines and medical devices. Continue reading “Access Board Working Group on Accessible Prescription Drug Container Labels”
WINAHEAD 